Apathy in Alzheimer's Disease

Overview

Journal Curr Opin Behav Sci

Date 2018 Aug 21

PMID 30123816

Citations 50

Authors

Lisa Nobis

Masud Husain

Affiliations

Soon will be listed here.

Abstract

Apathy is the most common neuropsychiatric symptom in patients with Alzheimer's disease (AD). The presence of apathy has been related to greater caregiver distress, decreased quality of life, and increased morbidity. Here we review the most recent studies on this neuropsychiatric syndrome, focusing on prevalence, impact on quality of life, behavioural and neuroimaging studies, and treatment options. The results of some investigations on the behavioural and neuroanatomical profile of apathy in AD point to a role of frontostriatal circuits, specifically involving the anterior cingulate cortex. However, small and heterogeneous samples, lack of control for disease severity, and non-specific apathy scales complicate interpretation of results. Future studies might benefit from studying multiple dimensions of apathy within conceptual frameworks which allow for a deconstruction of underlying mechanisms.

Citing Articles

Exploring apathy components and their relationship in cognitive decline: insights from a network cross-sectional study.

Sarti P, Varrasi S, Guerrera C, Platania G, Furneri G, Torre V BMC Psychol. 2025; 13(1):129.

PMID: 39962563 PMC: 11834197. DOI: 10.1186/s40359-024-02239-x.

rTMS Modulation of Behavioral and Biological Measures in 3xTg-AD Mice.

Kraybill E, Mojabi F, Heath A, Spikes C, Beard C, McNerney M Brain Sci. 2025; 14(12).

PMID: 39766385 PMC: 11674534. DOI: 10.3390/brainsci14121186.

The neural basis of neuropsychiatric symptoms in Alzheimer's disease.

Zhang N, Zhang S, Zhang L, Tao H, Zhang G Front Aging Neurosci. 2024; 16:1487875.

PMID: 39703925 PMC: 11655510. DOI: 10.3389/fnagi.2024.1487875.

A longitudinal multi-modal dataset for dementia monitoring and diagnosis.

Gkoumas D, Wang B, Tsakalidis A, Wolters M, Purver M, Zubiaga A Lang Resour Eval. 2024; 58(3):883-902.

PMID: 39323983 PMC: 11420249. DOI: 10.1007/s10579-023-09718-4.

Apathy in subarachnoid hemorrhage: study protocol for a 1-year follow-up study.

Tang W, Wong K Front Neurol. 2024; 15:1358102.

PMID: 39144716 PMC: 11322344. DOI: 10.3389/fneur.2024.1358102.

References

Kobayashi H, Ohnishi T, Nakagawa R, Yoshizawa K . The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis. Int J Geriatr Psychiatry. 2015; 31(8):892-904. PMC: 6084309. DOI: 10.1002/gps.4405. View

Sinha N, Manohar S, Husain M . Impulsivity and apathy in Parkinson's disease. J Neuropsychol. 2013; 7(2):255-83. PMC: 3836240. DOI: 10.1111/jnp.12013. View

Bayard S, Jacus J, Raffard S, Gely-Nargeot M . Apathy and emotion-based decision-making in amnesic mild cognitive impairment and Alzheimer's disease. Behav Neurol. 2014; 2014:231469. PMC: 4090525. DOI: 10.1155/2014/231469. View

You S, Walsh C, Chiodo L, Ketelle R, Miller B, Kramer J . Neuropsychiatric Symptoms Predict Functional Status in Alzheimer's Disease. J Alzheimers Dis. 2015; 48(3):863-9. PMC: 4751056. DOI: 10.3233/JAD-150018. View

Padala P, Padala K, Lensing S, Ramirez D, Monga V, Bopp M . Methylphenidate for Apathy in Community-Dwelling Older Veterans With Mild Alzheimer's Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. Am J Psychiatry. 2017; 175(2):159-168. DOI: 10.1176/appi.ajp.2017.17030316. View

Radakovic R, Starr J, Abrahams S . A Novel Assessment and Profiling of Multidimensional Apathy in Alzheimer's Disease. J Alzheimers Dis. 2017; 60(1):57-67. DOI: 10.3233/JAD-170292. View

Zhao Q, Tan L, Wang H, Jiang T, Tan M, Tan L . The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis. J Affect Disord. 2015; 190:264-271. DOI: 10.1016/j.jad.2015.09.069. View

Marin R, Biedrzycki R, Firinciogullari S . Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991; 38(2):143-62. DOI: 10.1016/0165-1781(91)90040-v. View

Dauphinot V, Delphin-Combe F, Mouchoux C, Dorey A, Bathsavanis A, Makaroff Z . Risk factors of caregiver burden among patients with Alzheimer's disease or related disorders: a cross-sectional study. J Alzheimers Dis. 2014; 44(3):907-16. DOI: 10.3233/JAD-142337. View

10.

Fernandez-Matarrubia M, Matias-Guiu J, Cabrera-Martin M, Moreno-Ramos T, Valles-Salgado M, Carreras J . Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2017; 33(1):141-150. DOI: 10.1002/gps.4695. View

11.

Donovan N, Wadsworth L, Lorius N, Locascio J, Rentz D, Johnson K . Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry. 2013; 22(11):1168-79. PMC: 3960369. DOI: 10.1016/j.jagp.2013.03.006. View

12.

Cummings J . The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology. 1997; 48(5 Suppl 6):S10-6. DOI: 10.1212/wnl.48.5_suppl_6.10s. View

13.

Riedijk S, de Vugt M, Duivenvoorden H, Niermeijer M, van Swieten J, Verhey F . Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease. Dement Geriatr Cogn Disord. 2006; 22(5-6):405-12. DOI: 10.1159/000095750. View

14.

Garcia-Alberca J, Lara J, Garrido V, Gris E, Gonzalez-Herero V, Lara A . Neuropsychiatric Symptoms in Patients With Alzheimer's Disease: The Role of Caregiver Burden and Coping Strategies. Am J Alzheimers Dis Other Demen. 2014; 29(4):354-61. PMC: 10852959. DOI: 10.1177/1533317513518649. View

15.

Rosenberg P, Lanctot K, Drye L, Herrmann N, Scherer R, Bachman D . Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry. 2013; 74(8):810-6. PMC: 3902018. DOI: 10.4088/JCP.12m08099. View

16.

Kozak M, Cuthbert B . The NIMH Research Domain Criteria Initiative: Background, Issues, and Pragmatics. Psychophysiology. 2016; 53(3):286-97. DOI: 10.1111/psyp.12518. View

17.

Spalletta G, Long J, Robinson R, Trequattrini A, Pizzoli S, Caltagirone C . Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease. J Alzheimers Dis. 2015; 48(3):627-36. DOI: 10.3233/JAD-150391. View

18.

Rea R, Carotenuto A, Traini E, Fasanaro A, Manzo V, Amenta F . Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial. J Alzheimers Dis. 2015; 48(2):377-83. DOI: 10.3233/JAD-141983. View

19.

Robert P, Clairet S, Benoit M, Koutaich J, Bertogliati C, Tible O . The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry. 2002; 17(12):1099-105. DOI: 10.1002/gps.755. View

20.

Chau S, Chung J, Herrmann N, Eizenman M, Lanctot K . Apathy and Attentional Biases in Alzheimer's Disease. J Alzheimers Dis. 2016; 51(3):837-46. DOI: 10.3233/JAD-151026. View